Skip to main content
Publications
Razavi P, Ahmed M, Roush A, Parikh R , Hitchens A , Shen S, Safonov A, Jhaveri K, Robson M, Peacock N, Ma Y, Santarsiero E, Ganapathy V, Shah R, Amaefule A, Lteif A, Blakely J. Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2− early breast cancer (EBC) treated with endocrine therapy (ET) in the US . J Clin Oncol. 2024 May;42(Suppl 16):e12533.
McElwee N, Willke R, Barrette E, Berger M, Cole A, Cortesi P, Earnshaw S , Garrison L, Gonzalez-Pier E, IJzerman M, Lee V, Hanson J, Mauskopf J, Reed S. Towards a vision for HEOR: opportunities for enhancement and evolution - an ISPOR health science policy council white paper . 2024. Available at: https://www.ispor.org/member-groups/councils-roundtables/health-science-policy-council. Accessed April 5, 2024.
Ogilvie RP, Layton JB , Wong HL, Jiao Y, Parambi RJ, Deng J, Miller M, Song J, Lloyd PC, Weatherby L, Peetluk LS, Bell EJ, Yang G, Amend KL, Kawai A , Lo AC, Matuska K, Wernecke M, Gruber JF, Clarke TC, Forshee RA, Anderson SA, Anthony MS , Chillarige Y, Seeger JD, Shoaibi A. Effectiveness of BNT162b2 COVID-19 vaccine in US children aged 5-17 years . Presented at the 39th ICPE Annual Conference; August 26, 2023. Halifax, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2023 Oct 12; 32(S1):78. doi: 10.1002/pds.5687
Layton JB , Peetluk LS, Wong H, Jiao Y, Ogilvie RP, Miller M, Glazier-Essalmi A, Parambi RJ, Song J, Garcia de Albeniz Martinez X , Lloyd PC, Lo A, Kawai A , Weatherby L, Bell EJ, Yang G, Amend KL, Gruber JF, Clarke TC, Forshee RA, Anderson SA, Wernecke M, Matuska K, Chillarige Y, Anthony M , Seeger JD, Shoaibi A. Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States . Presented at the 39th ICPE Annual Conference; August 27, 2023. Halifax, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2023 Oct 12; 32(S1):608. doi: 10.1002/pds.5687
Abtahi S, Pajouheshnia R , Duran-Salinas C, Riera-Arnau J, Gamba M, Alsina E, Hallgreen CE, Limoncella G, Bartolini C, Martin-Perez M, Brown J, Sturkenboom M, Klungel O, Other Lot4 Consortium Members of the Valproate study1. Impact of the 2018 pregnancy prevention program on the use of oral retinoids in childbearing age females in Europe . Presented at the 21st International Society of Pharmacovigilance (ISoP) Annual Meeting 2022; September 20, 2022. Verona, Italy. [abstract] Drug Saf. 2022 Aug 29; 45:1111-327. doi: 10.1007/s40264-022-01219-7
Boucher N, Van Voorhees E, Vashi A, Dong O , Morgan P, Smith JE, Adam S, Alishahi A, Mulholland MJ, Dietch JR, Whited JD, Boggan JC, Fulton JJ, Cameron CB, Gordon A, Goldstein KM, Ear B, Williams JW, Cantrell S, Dickerson SW, Gierisch JM. Tele-urgent care for low-acuity conditions: a systematic review . 2022.
Walters MC, Tisdale JF, Mapara MY, Krishnamurti L, Kwiatkowski JL, Aygun B, Kasow KA, Rifkin-Zenenberg S, Jaroscak J, Garbinsky D , Chirila C , Gallagher ME, Zhang X, Ho PR, Thompson AA, Kanter J. Sustained improvements in patient-reported quality of life up to 24 months post-treatment with LentiGlobin for sickle cell disease (bb1111) gene therapy . Presented at the 2021 63rd American Society of Hematology (ASH) Annual Meeting & Exposition; December 11, 2021. Atlanta, Georgia. [abstract] Blood. 2021 Nov 23; 138(Suppl 1):7. doi: 10.1182/blood-2021-146905
Motzer RJ, Porta C, Alekseev B, Rha SY, Choueiri TK, Mendez-Vidal MJ, Hong SH, Kapoor A, Goh JC, Eto M, Wang J , Pan J, Ayele Asfaw A, He CS, Mody K, Cella D. Health-related quality-of-life (HRQoL) analysis from the phase 3 CLEAR trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) or everolimus (EVE) versus sunitinib (SUN) for patients (pts) with advanced renal cell carcinoma (aRCC) . Presented at the 2021 ASCO Conference; June 4, 2021. [abstract] J Clin Oncol. 2021; 39(Suppl 15):4502.
Finlay J, Li M, Esposito M, Gomez-Lopez I, Khan A , Clarke P, Chenoweth M. National neighborhood data archive (NaNDA): arts, entertainment, and recreation organizations by ZIP code tabulation area, United States, 2003-2017 . 2020. doi: 10.3886/E125223V1
Finlay J, Li M, Esposito M, Gomez-Lopez I, Khan A , Clarke P, Chenoweth M. National neighborhood data archive (NaNDA): religious, civic, and social organizations by ZIP code tabulation area, United States, 2003-2017 . 2020. doi: 10.3886/E124721V1
Finlay J, Li M, Esposito M, Gomez-Lopez I, Khan A , Clarke P, Chenoweth M. National neighborhood data archive (NaNDA): religious, civic, and social organizations by census tract, United States, 2003-2017 . 2020. doi: 10.3886/E115967V2
Finlay J, Li M, Esposito M, Gomez-Lopez I, Khan A , Clarke P, Chenoweth M. National neighborhood data archive (NaNDA): liquor, tobacco, and convenience stores by ZIP code tabulation area, United States, 2003-2017 . 2020. doi: 10.3886/E123542V1
Finlay J, Li M, Esposito M, Gomez-Lopez I, Khan A , Clarke P, Chenoweth M. National neighborhood data archive (NaNDA): liquor, tobacco, and convenience stores by census tract, United States, 2003-2017 . 2020. doi: 10.3886/E123541V1
Spira AI, Chen L, Zhou X , Gnanasakthy A , Wang L, Ungar D, Curiel R, Radford JA, Kahl BS. Symptoms, health-related quality of life, and tolerability of loncastuximab tesirine in patients with relapsed or refractory diffuse large b cell lymphoma . Blood. 2020 Nov 5;136(Suppl 1):3-4. doi: 10.1182/blood-2020-139571
Finlay J, Li M, Esposito M, Gomez-Lopez I, Khan A , Clarke P, Chenoweth M. National neighborhood data archive (NaNDA): arts, entertainment, and recreation organizations by census tract, United States, 2003-2017 . 2020. doi: 10.3886/E115543V2